SCHEMBL9522093

SCHEMBL9522093

Cc1cc(CCCOc2ccc(-c3noc(C)n3)c(O)c2C)on1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
NR1I2 O75469 1/20 0.42
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TDP1 Q9NUW8 3/20 0.34
MAPT P10636 4/20 0.34
HSD17B10 Q99714 4/20 0.34
HPGD P15428 3/20 0.34
HTR1D P28221 3/20 0.34
HTR1B P28222 3/20 0.34
HTR2A P28223 3/20 0.34
KDM4E B2RXH2 3/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
S1PR1 P21453 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9520881 0.88 PPARA (0.35) CYP3A4CYP2D6NR1I2ALDH1A1MEN1
SCHEMBL13688008 0.83 NR1I2 (0.52) CYP3A4CYP2D6NR1I2ALDH1A1MEN1
SCHEMBL9523660 0.83 CYP3A4 (0.49) CYP3A4CYP2D6NR1I2ALDH1A1MEN1
SCHEMBL9523262 0.79 MAPT (0.35) CYP3A4CYP2D6ALDH1A1MEN1KMT2A
SCHEMBL9862882 0.74 ALDH1A1 (0.35) CYP3A4CYP2D6NR1I2ALDH1A1MEN1
SCHEMBL9200266 0.72 NR1I2 (0.73) CYP3A4CYP2D6NR1I2ALDH1A1MEN1
SCHEMBL9523473 0.71 NR1I2 (0.38) CYP3A4CYP2D6NR1I2ALDH1A1MEN1
SCHEMBL13623353 0.70 NR1I2 (0.71) CYP3A4CYP2D6NR1I2
SCHEMBL13623370 0.69 NR1I2 (0.61) CYP3A4CYP2D6NR1I2S1PR1L3MBTL1
SCHEMBL9520118 0.68 ESR1 (0.47) ALDH1A1MEN1KMT2AMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0523803-A1 1,2,4-Oxadiazolyl-phenoxy-alkylisoxazoles and their use as antiviral agents STERLING WINTHROP INC. (US) 1993-01-20 EP disclosed